ライフサイエンスコーパス: tobacco dependence

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 ophrenia have an exceptionally high risk for tobacco dependence.

2 y to nicotine may influence vulnerability to tobacco dependence.

3 ble, safe, and effective in the treatment of tobacco dependence.

4 fiant disorders, as well as with alcohol and tobacco dependence.

5 rm of treatment for individual patients with tobacco dependence.

6 vironmental and biological codeterminants of tobacco dependence.

7 ked to motivationally significant aspects of tobacco dependence.

8 d adverse effects with pharmacotherapies for tobacco dependence.

9 bling were significantly more likely to have tobacco dependence (84.0% versus 61.1%) and antisocial p

10 ctive models to manage chronic diseases like tobacco dependence across transitions in care.

11 duce early onset tobacco smoking and risk of tobacco dependence among smokers.

12 receptors (nAChRs) play an important role in tobacco dependence and a potential therapeutic role in n

13 w class of medications for treatment of both tobacco dependence and cannabis dependence.

14 r proposed approach to a genetic data set on tobacco dependence and found a significant interaction b

15 ype on chromosome 15 underlying the risk for tobacco dependence and lung cancer.

16 tion of new therapeutic targets for treating tobacco dependence and other addictions.

17 Both tobacco dependence and such conditions as diabetes are s

18 istration-approved medications used to treat tobacco dependence, bupropion and nicotine replacement t

19 king cessation could elucidate the nature of tobacco dependence, enhance risk assessment, and support

20 mplementation of fibrates as a treatment for tobacco dependence, especially in smokers with abnormal

21 Although the efficacy of pharmacotherapy for tobacco dependence has been previously demonstrated, the

22 While subjective aspects of tobacco dependence have been extensively examined as pre

23 duals with mental illness have high rates of tobacco dependence; however, little is known about what

24 ducation, including a lack of integration of tobacco dependence information throughout all 4 years of

25 quit smoking after discharge and received a tobacco dependence intervention in the hospital; 92% of

26 Tobacco dependence is a chronic, relapsing condition tha

27 Intensive intervention for tobacco dependence is a more effective smoking cessation

28 Tobacco dependence is an addiction with high rates of re

29 Tobacco dependence is difficult to treat, with the vast

30 Treating tobacco dependence is one of the most cost-effective act

31 The findings were specific for tobacco dependence; odds of marijuana dependence were no

32 Tobacco dependence should share the status of other chro

33 gave evidence of three classes pertinent to tobacco dependence syndrome in smokers by young adulthoo

34 ore likely to meet DSM criteria for lifetime tobacco dependence than offspring of mothers who reporte

35 multistakeholder committee with expertise in tobacco dependence treatment and/or LDCT screening.

36 ividualize the type, dosage, and duration of tobacco dependence treatment based on genotype, and maxi

37 ss of triple-combination pharmacotherapy for tobacco dependence treatment in these high-risk smokers

38 A particular challenge in tobacco dependence treatment is the development of effec

39 The optimal duration of tobacco dependence treatment is unknown, and some smoker

40 Combining pharmacotherapies for tobacco-dependence treatment may increase smoking abstin

41 betes are well covered by insurance, whereas tobacco dependence treatments are often limited.

42 nd naltrexone, have yielded mixed results as tobacco dependence treatments.

43 sorders, severe substance use disorders, and tobacco dependence were calculated using the Composite I

44 e management model is effective for treating tobacco dependence, which deserves as high a priority in

45 percentage of smokers receive treatment for tobacco dependence with counseling and/or medication, th

46 vity to which may influence vulnerability to tobacco dependence, yet mechanisms of nicotine avoidance

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。